Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech’s ...
The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At the same ...
Alvotech shares rose more than 6% in premarket trading Tuesday after the U.S. Food and Drug Administration approved a new manufacturing process for Simlandi, the company’s biosimilar to Humira.
HHS unveiled a new Alzheimer's and dementia plan in Fort Lauderdale focused on prevention and early detection. Here is what is promised and proven. Final CDC Data Put U.S. Fertility Rate at Record Low ...
Alvotech shares rose after the company said the Food and Drug Administration approved a new manufacturing process for Simlandi, its biosimilar to Humira. The stock was 8% higher, at $5.41, in morning ...
Povetacicept, an experimental drug for a rare kidney disease called IgA nephropathy (IgAN), has been declared a “breakthrough therapy” by the FDA. This status is given only to drugs that may treat a ...
Clene Nanomedicine has submitted an application to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of its experimental oral therapy CNM-Au8 for people with amyotrophic lateral ...
The U.S. Food and Drug Administration (FDA) on Thursday granted accelerated approval to AstraZeneca Plc’s AZN Ultomiris ...
HHS unveiled a new Alzheimer's and dementia plan in Fort Lauderdale focused on prevention and early detection. Here is what is promised and proven. Final CDC Data Put U.S. Fertility Rate at Record Low ...
GoodRx reports that FDA-approved peptides have undergone safety and effectiveness testing, while unapproved wellness peptides ...